open u201d wounds are within the scope of the invention preferably the wound is an u201c open u201d wound wherein the skin or mucosa is broken torn burnt cut or punctured preferred types of open wound would include abrasions burns and scalds incisions lacerations penetrations puncture and gunshot wounds the claimed morpholino compounds are known per se as disclosed in u s pat no 4 894 221 and u s pat no 5 082 653 which are incorporated herein by reference in the present invention the morpholino compounds are defined according to the general formula i shown above in a preferred embodiment of the present invention the sum of carbon atoms in the groups r 1 and r 2 is at least 10 and is preferably between 10 and 20 in a further preferred embodiment the r 2 group terminates with the hydroxy group the preferred morpholino compound for use in the present invention is 3 4 propyl heptyl 4 2 hydoxyethyl morpholine which is commonly known as delmopinol cas no 79874 76 3 the morpholino compounds of the present invention can be used in their free base form or as a pharmaceutically acceptable salt thereof some examples of pharmaceutically acceptable salts are the salts of acids such as acetic acid phosphoric acid boric acid hydrochloric acid maleic acid benzoic acid citric acid malic acid oxalic acid tartaric acid succinic acid glutaric acid gentisic acid valeric acid gallic acid beta resorcyclic acid acetyl salicylic acid salicylic acid perchloric acid barbituric acid sulfanilic acid phytic acid p nitro benzoic acid stearic acid palmitic acid oleic acid myristic acid lauric acid and the like the most preferred salt form is of hydrochloric acid a preferred compound is delmopinol hydrochloride cas no 98092 92.